• Skip to main content
  • Skip to after header navigation
  • Skip to site footer
American Head & Neck Society

American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

Donate
Your AHNS Member Panel
  • About
    • Mission Statement
    • Leadership
    • History
      • Society Background
      • AHNS History Interviews
      • Past Presidents
      • In Memory
    • Professionalism & Ethics Statement
    • AHNS Bylaws
    • AHNS Staff
    • AHNS News and Announcements
    • Divisions & Services of the Society
      • AHNS Foundation
      • AHNS Policies and Procedures (P&P) Manual
      • Education
        • Scientific Program/Resident Courses
        • Surgical Videos
        • Journal Club
        • Journals
        • Global Outreach
        • Awards
          • Margaret F. Butler Award
      • Diversity, Equity and Inclusion Division
      • Patient Care
        • Cancer Survivorship
          • Patient Education on Post-Treatment Care
          • Interviews with Cancer Survivors
        • Cancer Prevention
          • SLIDE DECK: HPV-Related Oropharyngeal Cancer
        • Guidelines/Position Statements
        • Find-A-Physician
      • Research
        • Grant Information
        • Clinical Trial
        • Tissue Banks
      • Administrative Division
        • AHNS Process for Evaluating Projects Requiring Funding
  • For Members
    • Join AHNS
    • Find-A-Physician
    • Mailing List Order
    • Post a Job
  • For Patients
    • Find-A-Physician
  • For Trainees
    • Fellowship Curriculum for FY2024-2025
      • For Current AHNS Fellows
      • Certificate of Completion Request
    • Accredited Fellowships
      • Directory of Fellowships
      • AHNS Fellowship Match
      • Fellowship Curriculum
      • Fellowship Graduates
      • For Program Directors
    • AHNS Surgical Videos
    • Fellows’ Virtual Tumor Boards
    • Cutaneous Cancer
  • Sections
    • Endocrine Surgery
    • Skull Base Surgery Section
    • Reconstructive Head & Neck Surgery
      • Head and Neck Reconstruction- Information for Patients
    • Mucosal Malignancy Section
      • Mucosal Malignancy Section Patient Information
    • Salivary Gland Section
      • Salivary Gland Section Patient Education Handout: Parotidectomy
    • Cutaneous Cancer
  • Meetings
    • AHNS Virtual Education Series
      • TORS Webinar Series
    • AHNS 2026 Meetings Info
    • AHNS Call For Abstracts
    • Past Meetings
    • Related Meetings
  • Heads Up!
  • Job Board
  • Your AHNS Member Panel
  • Donate
  • Login
    • Password Reset

New Grant Opportunity from SU2C in Head and Neck Cancer: LOI Deadline March 22, 2021

March 9, 2021 by AHNS Webmaster

Head and neck cancer is a blanket term used to describe several different types of cancers.
About 65,000 new cases, not counting thyroid cancer, are diagnosed in the U.S. every year.
A number of causes of these cancers have been identified, potentially offering new
opportunities to screen for the cancers and create new treatments for patients.

For example, the incidence of head and neck squamous cell carcinoma in people with
Fanconi anemia is 500- to 700-fold higher than in the general population. Additionally up to
70% of certain head and neck cancers are caused by human papillomavirus (HPV) infection.
Genetic defects that cause Fanconi anemia, as well as genetic changes resulting from HPV
infection, both adversely affect DNA repair systems, which can lead to cancer. This similarity
provides investigators with different perspectives on a common problem and the opportunity
to collaborate in new and innovative ways.

Head and neck cancers can appear in the nasal cavity, sinuses, lips, mouth, salivary glands,
thyroid gland, throat or larynx. Experts estimate there are about 550,000 cases of various
kinds of head and neck cancer diagnosed around the world each year, with 300,000 annual
deaths due to the cancers. Research has also shown that Black people have higher
incidence of head and neck cancer and a lower 5-year survival rate compared to white
people. Black patients are also typically diagnosed with more advanced head and neck
cancer.

To unlock potential new treatments, Stand Up To Cancer, with the generous support of the
Fanconi Anemia Research Fund, the Farrah Fawcett Foundation, the American Head and
Neck Society, and the Head and Neck Cancer Alliance, is offering up to $3.25 million in
grants to fund research to find new treatments for head and neck cancer. The team will have
a special focus on head and neck cancers associated with Fanconi anemia and HPV. Applicants will need to ensure that people from medically disadvantaged backgrounds are included in all phases of their proposed research.

Further information and a link to the application

visit StandUpToCancer.org/HeadandNeck.

 

Share:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn

Related

Category: Blog

About AHNS Webmaster

I am the webmaster for the American Head and Neck Society and have been since 2003 or so.

Previous Post:When should sentinel node biopsy be used for cutaneous squamous cell carcinoma?
Next Post:Myers’ Family Summer Travel Fellowship in Otolaryngology Application is Open

Copyright © 2025 · American Head & Neck Society · All Rights Reserved